Dopamine agonists such as pramipexole, ropinirole, rotigotine, and apomorphine have long been recommended as initial therapy for younger patients with Parkinson’s disease, typically those younger than ...
Dopamine agonists are medications that mimic the effects of dopamine, which can be helpful if you have low dopamine levels. Dopamine is a complex and key neurotransmitter responsible for many of our ...
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. These receptors ...
Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...
Morning Overview on MSN
An experimental Parkinson’s pill is nearing a make-or-break FDA decision
Millions of people living with Parkinson’s disease may soon have a new treatment option on the table. AbbVie has submitted a ...
When the researchers administered a long-acting KOR blocking drug to these mice, they found that the agent reduced the expression of the mutant transporter on the cell surface where it normally ...
New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications. The study, including experiments in ...
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. These receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results